Altium Capital Management LLC
In its 13F for Q3 2025 (holdings as of September 30, 2025, filed November 4, 2025), Altium Capital Management LLC reported 1 stock position worth $628 thousand. Its top holding was Plus Therapeutics (CNSY) at 100.0% of the portfolio.
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001746382
- Portfolio Value
- $628K (Q3 2025)
- SEC Filing
- 0001420506-25-002984 ↗ filed Nov 4, 2025
Holdings Value
Holdings 1 stocks · $628K
| CNSY Plus Therapeutics Inc. | 100.00% | 918,914 | $628K | — |
Portfolio Sells Q3 2025
No earlier filing to compare with.
Portfolio Buys Q3 2025
No earlier filing to compare with.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 19 | $47.5M | RMT, ASA, RVT, NBXG, PDX |
| Q1 2026 | 19 | $42.0M | PDX, ASA, RVT, XPCQX, GAM |
| Q4 2025 | 18 | $25.3M | ASA, RVT, PDX, NBXG, XPCQX |
| Q3 2025 | 1 | $628K | CNSY |
| Q2 2025 | 0 | $0 | |
| Q1 2025Amended | 22 | $34.4M | ZVRA, EOLS, XTNT, AVDL, CTNM |
| Q4 2024 | 61 | $321.1M | ADMA, VERA, SRPT, ZVRA, ESTA |
| Q3 2024 | 57 | $334.9M | VERA, ADMA, SRPT, EW, XENE |
| Q2 2024 | 45 | $241.2M | VERA, ADMA, XENE, ITCI, SRPT |
| Q1 2024 | 46 | $222.3M | VERA, XENE, AXSM, ADMA, ALIM |